Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

NCT00562458 ·Status: COMPLETED

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

NCT00301457 ·Status: COMPLETED ·Phase: PHASE3

Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors

NCT03144037 ·Status: COMPLETED

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

NCT00077025 ·Status: COMPLETED ·Phase: PHASE2

Study of Arimidex and Radiotherapy Sequencing

NCT01402193 ·Status: UNKNOWN ·Phase: PHASE3

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

NCT00357110 ·Status: COMPLETED ·Phase: PHASE2

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

Arthralgia During Anastrozole Therapy for Breast Cancer

NCT00323479 ·Status: COMPLETED ·Phase: PHASE4

Liver Safety Under Upfront Arimidex vs Tamoxifen

NCT00537771 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment

NCT00737009 ·Status: COMPLETED

Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

NCT00859560 ·Status: COMPLETED

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

NCT00570323 ·Status: COMPLETED ·Phase: PHASE2

Adherence to Aromatase Inhibitors: The Role of Partners

NCT02753985 ·Status: COMPLETED

Factors Influencing Adherence to Adjuvant Endocrine Therapy

NCT06192446 ·Status: RECRUITING

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

NCT00143390 ·Status: COMPLETED ·Phase: PHASE3

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

NCT03351062 ·Status: RECRUITING ·Phase: PHASE3

Breast Cancer Tumor Care Observational Programme

NCT00660244 ·Status: COMPLETED

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

NCT00767585 ·Status: COMPLETED

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

NCT00003418 ·Status: UNKNOWN ·Phase: PHASE3

Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients

NCT05730647 ·Status: ACTIVE_NOT_RECRUITING

eHealth Intervention for Medication Adherence in Breast Cancer Survivors

NCT05324020 ·Status: COMPLETED ·Phase: NA